Revumenib as A New Therapeutic Intervention for Relapsed or Refractory KMT2A-Rearranged Acute Lymphoblastic Leukemia

KMT2A (MLL)-rearranged acute lymphoblastic leukemia (ALL) is one of the most severe forms of leukemia that corresponds with high mortality, especially in relapsed or refractory cases. ALL affects both adults and children, thereby necessitating the need for treatment options that provide higher effi...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Khushbakht Baloch, Muniba Shoaib, Mishal Fatima
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	ziauddin University 2025-04-01
Saila:	Pakistan Journal of Medicine and Dentistry
Gaiak:	Acute leukemia Acute leukemia treatment Revumenib Abbreviations: 1 Acute Lymphoblastic Leukemia (ALL)
Sarrera elektronikoa:	https://ojs.zu.edu.pk/pjmd/article/view/3582
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!